Inventor · disambiguated record
Xia Peng
Also filed as: PENG XIA
11 granted patents·3 pending applications·4 citations·filing 2013–2023
79Inventor score
Files withSHANGHAI INST MATERIA MEDICA CAS6SHANGHAI FOCHON PHARMACEUTICAL CO LTD2HAIHE BIOPHARMA CO LTD1LI LI1PENG XIA1
Top patents by PatentIndex Score
14 records- 0173US9206166B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2013·Granted Dec 8, 2015·2 cites·20 claims
- 0255USD1037596SDraining matPENG XIA·Filed 2023·Granted Jul 30, 2024·2 cites·1 claims
- 0348US12479850B2Compound having Axl and c-Met kinase inhibitory activity, preparation thereof and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Nov 25, 2025·0 cites·7 claims
- 0445US12497394B2Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted Dec 16, 2025·0 cites·12 claims
- 0545US11759423B2Exosome preparation for treating disease and application thereofLI LI·Filed 2017·Granted Sep 19, 2023·0 cites·2 claims
- 0643US9988381B2Five-member-heterocycle fused pyridine compounds, method of producing the same, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2014·Granted Jun 5, 2018·0 cites·21 claims
- 0742US9567342B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Feb 14, 2017·0 cites·20 claims
- 0841US11834432B2Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Dec 5, 2023·0 cites·16 claims
- 0941US11655239B2Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereofSHANGHAI INSTITUTE OF MAT MEDICA CHINESE ACADEMY OF SCIENCES·Filed 2020·Granted May 23, 2023·0 cites·16 claims
- 1039US10988456B2O-aminoheteroaryl alkynyl-containing compound, preparation method therefor, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2018·Granted Apr 27, 2021·0 cites·17 claims
- 1137US10080797B2Oncolytic heterologous recombinant newcastle disease virus, preparation method and application thereofZHAO YONGXIANG·Filed 2016·Granted Sep 25, 2018·0 cites·18 claims
- 1234US2019135818A15-membered heterocycle fused with [3,4-d] pyridazinone, and manufacturing method, pharmaceutical composition, and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Application pending·0 cites
- 1333US2016145244A1Certain protein kinase inhibitorsWANG WEIBO·Filed 2015·Application pending·0 cites
- 1432US2021078972A1Quinoline or quinazoline compound and application thereofHAIHE BIOPHARMA CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xia Peng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →